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Widespread distribution of Plasmodium 
vivax malaria in Mauritania on the interface 
of the Maghreb and West Africa
Hampâté Ba1*, Craig W. Duffy2, Ambroise D. Ahouidi3, Yacine Boubou Deh1, Mamadou Yero Diallo1, 
Abderahmane Tandia1 and David J. Conway2*
Abstract 
Background: Plasmodium vivax is very rarely seen in West Africa, although specific detection methods are not widely 
applied in the region, and it is now considered to be absent from North Africa. However, this parasite species has 
recently been reported to account for most malaria cases in Nouakchott, the capital of Mauritania, which is a large 
country at the interface of sub-Saharan West Africa and the Maghreb region in northwest Africa.
Methods: To determine the distribution of malaria parasite species throughout Mauritania, malaria cases were 
sampled in 2012 and 2013 from health facilities in 12 different areas. These sampling sites were located in eight major 
administrative regions of the country, within different parts of the Sahara and Sahel zones. Blood spots from finger-
prick samples of malaria cases were processed to identify parasite DNA by species-specific PCR.
Results: Out of 472 malaria cases examined, 163 (34.5 %) had P. vivax alone, 296 (62.7 %) Plasmodium falciparum 
alone, and 13 (2.8 %) had mixed P. falciparum and P. vivax infection. All cases were negative for Plasmodium malariae 
and Plasmodium ovale. The parasite species distribution showed a broad spectrum, P. vivax being detected at six of 
the different sites, in five of the country’s major administrative regions (Tiris Zemmour, Tagant, Brakna, Assaba, and the 
capital Nouakchott). Most cases in Nouakchott were due to P. vivax, although proportions vary significantly among 
different health facilities in the city. In the northern town of Zouérat, all cases were due to P. vivax, whereas almost all 
cases in the south of the country were due to P. falciparum. All P. vivax cases tested were Duffy blood group positive.
Conclusions: It is important that P. vivax is recognized to be a widespread cause of malaria in Mauritania, occurring in 
diverse regions. This should be noted by the World Health Organization, as it has significant implications for diagnosis, 
treatment and control of malaria in the northwestern part of Africa.
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Background
Most malaria cases in Africa are caused by Plasmodium 
falciparum [1], with a relatively small proportion attrib-
utable to Plasmodium malariae or Plasmodium ovale, 
while Plasmodium vivax is known to occur in only 
some areas of the continent [2, 3]. Following scale-up of 
prevention and treatment, the incidence of malaria has 
significantly declined in some areas, contributing to a 
reduction in overall mortality [4, 5]. Although most of 
West Africa still has a high malaria burden, numbers of 
cases have markedly declined near the northwestern end 
of the endemic distribution [1, 6, 7]. More studies are 
needed in areas closer to the edge of endemicity, where 
seasonal transmission is normally very limited.
The country of Mauritania is at the extreme northwest-
ern limit of malaria distribution in Africa. It has a popu-
lation of approximately 3.5 million people, and covers a 
large area of 1,030,700 sq km2, lying between 15 and 27°N 
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latitude, and 5 and 17°W longitude. Malaria is considered 
to be the third most common cause of clinical presenta-
tion to health facilities in the country. Although a large 
part of the territory is Saharan desert, malaria is most 
common in areas of Sahel in the south of the country, 
and has been increasingly seen in Nouakchott, the capi-
tal city that contains approximately 25 % of the country’s 
inhabitants [8–10]. Recent reports indicate that P. vivax 
is more commonly seen than P. falciparum in patients 
with malaria in Nouakchott [9–12]. This represents an 
apparently unique epidemiological situation, as P. vivax 
has been very rarely or never seen at most other sites 
in West Africa [2, 3, 13–15]. One factor contributing to 
this is that most inhabitants in Nouakchott are ethnically 
identified as white Maures, who are generally positive for 
the Duffy antigen erythrocyte receptor for P. vivax, which 
is rare among other West African ethnic groups living 
mostly in the south of the country [16]. A second factor 
is that local breeding of the mosquito vector Anopheles 
arabiensis has been facilitated by surface water environ-
ments, created by loosely regulated urbanization over 
recent decades in an area that was originally desert [12].
Outside of the capital Nouackchott, the limited slide 
microscopy surveys conducted historically have indi-
cated that almost all malaria cases are due to P. falcipa-
rum, apart from occasional cases reportedly being due 
to P. malariae and P. ovale [8]. P. vivax has not been 
clearly described at other sites, except for a few infec-
tions detected in 2009 and 2010 in the Hodh El Gharbi 
region in the south of the country [17], although it has 
been suspected elsewhere. As there have been few recent 
surveys, and identification of species by slide microscopy 
is often unreliable, a broad survey using molecular meth-
ods for species identification is needed. In this study, the 
distribution of parasite species in malaria cases was sur-
veyed by sampling from health facilities at diverse sites 
throughout Mauritania.
Methods
Patients with malaria were sampled from among those 
attending 14 health facilities at 12 different geographi-
cal sites in eight administrative regions of Mauritania in 
2012 and 2013 (Fig. 1). Three of the facilities were within 
the capital city Nouakchott: the National Hospital Cen-
tre, Cheikh Zayed Hospital Centre and Teyarett Health 
Centre, the first of which serves a broad population of 
mixed ethnicity, while the other two serve areas pre-
dominantly inhabited by white Maures. The large urban 
area of Nouakchott typically receives only 50 to 100 mm 
annual rainfall but has a large supply of piped water from 
the south of the country. One of the other sites sampled 
was far outside of the known malaria-endemic area, in 
the mining town of Zouérat (Tiris Zemmour Region) 
in the north of the country, which usually receives less 
than 50 mm of rain annually. The remaining nine health 
facilities were in different towns and villages through-
out ecologically diverse parts of the country known to 
be endemic for malaria: Boghé (Brakna Region) in the 
Senegal River valley generally receives between 200 and 
300 mm annual rainfall; Sélibaby and Ould Yenge (Gui-
dimakha Region) within 100  km of the Senegal River 
valley receive between 300 and 600 mm annual rainfall; 
Aioun and Kobenni (Hodh El Garbi Region), Timbédra 
and Néma (Hodh El Chargi Region), and Kiffa (Assaba 
Region) are in a semi-arid zone where average rainfall 
varies between approximately 100 and 300 mm; N’beika 
and Tidjikja (Tagant Region), are in an arid zone which 
usually receives only between 50 and 200  mm of rain 
annually (Fig.  1). The limited and variable annual rain-
fall in Mauritania mostly occurs between July and Octo-
ber, leading to seasonal malaria, so cases were sampled 
between August and December in each year.
Patients were diagnosed with uncomplicated clini-
cal malaria by local health facility staff on the basis of 
clinical signs including the presence of fever, supported 
by positive rapid diagnostic tests detecting circulating 
malaria parasite lactate dehydrogenase (OPTIMAL-IT 
TM kits incorporating two different antibodies that are, 
respectively, P. falciparum species-specific and broadly 
Plasmodium-specific). Tests that are negative for P. falci-
parum but positive for Plasmodium are routinely consid-
ered to be likely due to either P. malariae, P. ovale, or P. 
vivax, although resolution of these alternative species is 
not done at diagnosis in most health facilities. All cases 
analysed were local residents who did not report hav-
ing travelled within the previous 2 weeks, and who were 
invited to provide finger-prick blood samples. These 
were collected on filter paper and air-dried prior to stor-
age with desiccant in sealed polythene bags. All samples 
were obtained with informed consent from patients, and 
guardians of patients who were under 18  years of age. 
Regardless of inclusion in the study, patients were treated 
at the health facilities with artemisinin combination ther-
apy. Current recommendations of the National Malaria 
Control Programme are for first-line treatment combi-
nation of artesunate and amodiaquine, and second-line 
treatment option of artemether and lumefantrine, with 
primaquine being added in the case of confirmed P. vivax 
infection. The study was approved by ethics committees 
of the Ministry of Health of Mauritania and the London 
School of Hygiene and Tropical Medicine.
DNA was extracted from filter paper blood spots using 
QIAmp DNA Minikits (Qiagen, Valencia, CA, USA). 
Species-specific identification of malaria parasites by 
nested PCR was performed using a published method 
[18], with a first round of Plasmodium genus-specific 
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PCR followed by species-specific amplification using 
primers to detect P. falciparum, P. vivax, P. malariae, 
and P. ovale. Products were separated electrophoretically 
on 1 % agarose gels, stained with ethidium bromide and 
visualized using ultraviolet trans-illumination for pho-
tography and scoring. Positive and negative controls were 
included in all assays, with DNA from different malaria 
species kindly provided by Colin Sutherland from the UK 
Malaria Reference Laboratory.
A proportion of individuals sampled were genotyped 
to test for Duffy blood group negativity, based on the 
GATA-1 gene promoter allele that leads to null expres-
sion in West African populations, using a previously pub-
lished protocol [19].
Results
Overall, 472 patients sampled had malaria parasites 
detected by Plasmodium genus-specific as well as spe-
cies-specific PCR analyses. Of these, 296 (62.7  %) had 
P. falciparum alone, 163 (34.5  %) P. vivax alone, and 13 
(2.8 %) had mixed P. falciparum and P. vivax infections. 
None of the samples was positive for P. ovale or P. malar-
iae. Apart from Nouakchott, in which infections were 
already known to occur, P. vivax is described here for the 
first time from five widely separated sites in four other 
administrative regions of Mauritania (Tiris Zemmour, 
Tagant, Brakna, and Assaba). The proportions of malaria 
cases with P. vivax and P. falciparum showed extreme 
variation among the different sites (Table 1). This ranged 
from a situation at six sites in the southeast of the country 
at which all cases detected were P. falciparum, through to 
the opposite extreme at Zouérat in the north of the coun-
try at which all cases were P. vivax. Both malaria parasite 
species were present at the remaining sites (Fig. 2).
In the capital Nouakchott, P. vivax was more common 
than P. falciparum in both 2012 and 2013. Overall, there 
was no significant difference between the 2 years in the 
relative proportion of the two parasite species. However, 
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Fig. 1 Map of Mauritania showing the locations of the sampling sites in relation to average annual rainfall and previously known areas of malaria 
endemicity. a Malaria patients were sampled from 12 locations in Mauritania. In the capital city Nouakchott (Location 1) sampling was conducted 
from three hospitals: Health Centre of Teyarett, Cheikh Zayed Hospital Center, and the National Hospital Centre. Sampling was conducted from 
single facilities in each of the other 11 locations: hospitals in Sélibaby, Aioun, Néma and Zouérat, and health centres in each of the other locations. 
Malaria parasite species were determined from 472 patients in total (numbers from each location are given in Table 1). The approximate mean 
annual rainfall in millilitres in different areas is indicated by isohyets shown as dashed lines. b. Inset rectangles indicate the position of the study area 
map on previously published maps of malaria parasite distribution in Africa [1, 3]. Estimated endemic distributions of P. falciparum and P. vivax in 
2010 are indicated by coloured shading (blue indicating low prevalence, yellow and red indicating higher prevalences). Grey shading indicates where 
sporadic transmission is considered possible without endemic maintenance. In the lower map the diagonal shading indicates where the majority of 
the population has the Duffy-negative blood group phenotype
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within each year there were differences in the propor-
tions of species between the different health facilities 
sampled in Nouakchott (Table  2). At Teyarett Health 
Centre in both years, most malaria cases were caused 
by P. vivax, whereas in the other two hospitals sampled 
separately in the respective years there were more equal 
proportions of both P. vivax and P. falciparum. In 2012, 
85 % (49/53) of cases sampled from Teyarett Health Cen-
tre had P. vivax alone, in contrast with 37  % (16/43) at 
the National Hospital Centre (Fisher’s Exact P < 0.0001). 
In 2013, 85  % (62/73) of cases sampled from Teyarett 
Health Centre had P. vivax alone, in contrast with 43 % 
(3/7) at the Cheikh Zayed Hospital Centre (Fisher’s Exact 
P = 0.013).
Duffy promoter genotyping of 82 P. vivax positive cases 
did not show any individual to be homozygous Duffy 
negative.
Discussion
In contrast to the situation in other West African coun-
tries, P. vivax is a widely distributed cause of clinical 
malaria in Mauritania. Cases occur over a large area, and 
are not restricted to the capital Nouakchott from where 
they were previously described. Remarkably, there is no 
information on the occurrence of this parasite species 
in country malaria reports for Mauritania given by the 
World Health Organization [5]. This study shows that 
the species exists alongside P. falciparum in the central 
Table 1 Proportions of  P. vivax and  P. falciparum infections detected in  malaria cases sampled from  12 different areas 
in Mauritania
Individual locations are shown on Fig. 1. Samples from Nouakchott were from three different health facilities, and proportions of species at each of these are shown in 
Table 2
a Relative proportions of each species at each site are estimated by counting numbers of infections with each species, with each being counted separately from 
mixed species infections
Location and year  
of sampling
Number
positive
P. vivax  
alone
P. falciparum  
alone
P. vivax and
P. falciparum  
mixed
Proportion of 
P. vivax
(Pv/[Pv + Pf])a
2012
 Aioun 30 0 30 (100 %) 0 0.00
 Boghé 8 1 (13 %) 7 (88 %) 0 0.13
 Kobenni 131 0 131 (100 %) 0 0.00
 N’beika 6 4 (67 %) 1 (17 %) 1 (17 %) 0.71
 Tidjikja 3 1 2 0 0.33
 Timbédra 17 0 17 (100 %) 0 0.00
 Nouakchott 96 65 (68 %) 20 (21 %) 11 (11 %) 0.73
2013
 Sélibaby 29 0 29 (100 %) 0 0.00
 Kiffa 9 2 (22 %) 7 (78 %) 0 0.22
 Ould Yenge 14 0 14 (100 %) 0 0.00
 Zouérat 25 25 (100 %) 0 0 1.00
 Néma 24 0 24 (100 %) 0 0.00
 Nouakchott 80 65 (81 %) 14 (18 %) 1 (1 %) 0.81
200 km
Mauritania
Western 
Sahara
Senegal
Mali
Algeria
P. vivax P. falciparum mixed P. vivax / P. falciparum
Fig. 2 Proportions of Plasmodium vivax and Plasmodium falciparum 
malaria cases at each of 12 locations sampled in Mauritania shown 
by pie diagrams. The locations are as specified in Fig. 1. The size of 
pies varies according to the number of PCR positive cases analysed at 
each site: small, <20; medium, 20–100; large, >100. Exact numbers are 
given in Table 1
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and southwest parts of the country (Tagant, Brakna and 
Assaba regions), and in Nouakchott where its relative 
frequency as a cause of malaria varies between differ-
ent health facilities. Notably, P. vivax was the only para-
site species seen in malaria patients from Zouérat in the 
north of the country (Tiris Zemmour region), whereas in 
the southeast of the country it is clear that P. falciparum 
dominates and P. vivax is rarely seen.
The epidemiology of malaria in these communities 
needs to be better understood. It is possible that P. vivax 
might be maintained in areas with minimal transmis-
sion in the centre and north of the country due to long 
persistence of infection in individuals experiencing 
occasional relapse from dormant hypnozoite stages in 
the liver. As samples were from individuals who had not 
reported travelling within the previous 2 weeks, most 
of the cases were probably acquired locally, although 
some might have been due to relapses of P. vivax infec-
tions acquired previously. A study of malaria in north-
ern Senegal near the border with Mauritania surveyed 
households of index cases [20], revealing that many P. 
falciparum infections are associated with travel to more 
highly endemic parts of Senegal. Surveys based around 
index cases may also be useful to understand the epide-
miology of P. vivax as well as P. falciparum in different 
parts of Mauritania. Although there is a previous report 
of a P. vivax-infected individual in Nouakchott who was 
Duffy negative [16], in the present study all cases of P. 
vivax tested were shown to be Duffy positive. Indeed, 
where P. vivax was seen to be clearly the predominant 
cause of malaria, for example in the Teyarett area of 
Nouakchott and in the northern town of Zouérat, most 
of the local population are white Maures, an ethnic-
ity highly associated with Duffy positivity. Therefore, 
this parasite species will probably remain rare in the 
extreme south of Mauritania where most of the popula-
tion are Duffy negative, but its widespread distribution 
in the central and northern parts of the country needs 
to be monitored and addressed.
Although the distributions of P. vivax and P. falcipa-
rum differ globally [21], it is remarkable that P. vivax as 
a widespread cause of malaria in communities living in 
desert and Sahel areas of West Africa has not been previ-
ously appreciated. The situation described here in Mau-
ritania, and recent data on a limited number of positive 
samples in Senegal [22] and northern Mali [14, 15], sug-
gest that P. vivax is likely to be endemic in many commu-
nities living in other parts of northwestern Africa which 
have yet to be surveyed with species-specific methods 
[2]. There is recent evidence suggesting that P. vivax 
emerged prehistorically as a zoonosis from African apes 
prior to becoming endemic in humans and then spread-
ing to other continents [23]. It remains to be determined 
whether the current P. vivax distribution in Mauritania 
is part of a relict African parasite population, or whether 
the species was re-introduced in historical times.
Conclusions
Plasmodium vivax causes a substantial proportion of 
malaria cases in diverse parts of Mauritania. Far from 
being restricted to the capital Nouakchott, P. vivax is 
detected from five of the major administrative regions 
of this large country, including one northern town in 
which all cases sampled were caused by this species. This 
has significant implications for diagnosis, treatment and 
control of malaria in this part of northwest Africa, so 
reporting and advice by the World Health Organization 
and other authorities need to reflect the epidemiological 
situation.
Authors’ contributions
HB and DJC conceived and designed the study. HB, CWD, AAD, TBD, MYD, and 
AT collected the samples and performed laboratory assays. HB, CWD, AAD, 
and DJC performed data analysis and interpretation. HB and DJC wrote the 
manuscript. All authors read and approved the final manuscript.
Table 2 Proportions of malaria infections containing P. vivax and P. falciparum at each of three health facilities sampled 
in Nouakchott, the capital of Mauritania
a Relative proportions of each species at each hospital are estimated by counting numbers of infections with each species, with each being counted separately from 
mixed species infections
Health facility
 and year of sampling
Number of
 cases sampled
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